NVIDIA reportedly introduced about twenty or so new AI-driven tools tailored for healthcare at its 2024 GTC AI conference, securing partnerships with Johnson & Johnson and GE Healthcare for surgical and medical imaging applications.
For the AI chip pioneer, venturing into healthcare represents a decade-long development effort with substantial revenue possibilities.
The adoption of AI in drug discovery and research, a process that traditionally takes up to 12 years and costs billions, is accelerating rapidly.
The opportunities will be far reaching.
Nvidia one year chart
